![Alex Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 30/06/2026
Alex Wilson currently works at AEON Biopharma, Inc. as Secretary, Chief Legal Officer & Executive VP since 2021.
Formerly, Mr. Wilson worked at Glaukos Corp.
as Associate General Counsel & Business Development and at O'Melveny & Myers LLP as Head-Counsel.
Education includes undergraduate studies at Brigham Young University and graduate studies at UCLA School of Law.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AEON BIOPHARMA, INC. | Consigliere Generale | 01/08/2021 |
| Società | Posizione | Fine |
|---|---|---|
| GLAUKOS CORPORATION | Corporate Officer/Principal | 01/08/2021 |
O'Melveny & Myers LLP
 O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Consigliere Generale | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 5 |
|---|---|
Glaukos Corp.
 Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
O'Melveny & Myers LLP
O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA School of Law
 UCLA School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AEON Biopharma, Inc.
 AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
